Novation cuts new deals with medical device giants
February 4, 2013 by MassDevice staff
Novation picks up new product lines from Teleflex, Covidien and others.
Group purchasing organization Novation negotiated a sweeping deal for a new line of wound closure devices that includes a group of top suppliers, such as 3M Co. (NYSE:MMM), Applied Medical, Cardinal Health (NYSE:CAH), Covidien (NYSE:COV), DeRoyal, Genicon, Johnson & Johnson (NYSE:JNJ), Medline Industries and Teleflex (NYSE:TFX).
The deal encompasses a wide variety of endomechanical products including sutures, skin staples, endoscopic instruments and topical skin adhesives. Novation's priority was to ensure "flexibility and product choice" to its surgeons, according to a press release. The agreement is slated to take effect April 1.
Sign up to get our free newsletters delivered straight to your inbox
Similar entries
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
- Physician blogger insights on social media
Navigation
NEWS
Pluristem launches Phase I clinical trial to treat tendonitis with stem cells
Pluristem is seeking clinical proof that stem cell therapy can benefit patients with chronic...
GE Healthcare unveils soft tissue imaging technology
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint...
Hip implants: Johnson & Johnson's DePuy will stop selling metal-on-metal implants
Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-...
Combat Medical Systems wins 1st-of-its kind approval for tourniquet
The FDA approves a novel combat-ready clamp to treat wounds most commonly associated with roadside or...
Vascular Solutions CEO: Boston Scientific's alleged patent infringement 'blatant'
Vascular Solutions CEO Howard Root says alleged infringement by Boston Scientific's Guidezilla "is...
